Valuation: Rani Therapeutics Holdings, Inc.

Market Cap 76.77M 67.08M 61.6M 57.45M 109M 7.31B 111M 742M 287M 3.58B 288M 282M 12.35B P/E 2026 *
-3.97x
P/E 2027 * -3.49x
Enterprise Value 76.77M 67.08M 61.6M 57.45M 109M 7.31B 111M 742M 287M 3.58B 288M 282M 12.35B EV / Sales 2026 *
18.6x
EV / Sales 2027 * 15.6x
Free-Float
78.28%
Yield 2026 *
-
Yield 2027 * -
1 day+0.26%
1 week+3.79%
Current month+1.32%
1 month-10.18%
3 months-8.26%
6 months-43.35%
Current year-42.93%
1 week 0.72
Extreme 0.72
0.82
1 month 0.72
Extreme 0.72
0.92
Current year 0.68
Extreme 0.68
1.54
1 year 0.39
Extreme 0.387
3.87
3 years 0.39
Extreme 0.387
8.75
5 years 0.39
Extreme 0.387
36.27
10 years 0.39
Extreme 0.387
36.27
Manager TitleAgeSince
Chief Executive Officer 45 01/06/2021
Director of Finance/CFO 46 29/06/2026
Chief Tech/Sci/R&D Officer 42 01/01/2022
Director TitleAgeSince
Chairman 69 01/06/2021
Director/Board Member 80 01/09/2018
Director/Board Member 69 06/04/2021
Date Insider Type Main position Quantity % Market Cap.
06-03Free

Founder

3,800,000 3.8106%
06-03Free

Executive/Senior Manager

805,500 0.8077%
06-03Free

Chief Technology Officer

805,500 0.8077%
Change 5-day change 1-year change 3-year change Capi.($)
+0.30%+3.79%+44.87%-80.93% 76.77M
+3.98%+10.23%+73.54%+132.19% 56.21B
-3.12%+5.11%+71.57%+94.67% 55.38B
-8.28%+8.04%-10.18%-9.81% 23.75B
+3.17%+5.57%+12.27%+431.52% 23.19B
+3.64%+10.54%+39.81%-4.50% 18.14B
+4.11%+8.89%+44.60%-27.73% 16.84B
+2.57%+20.26%+181.98%+355.99% 15.86B
+5.46%+3.88%+24.82%+189.06% 13.56B
+7.20%+10.70%+42.91% - 12.97B
Average +2.78%+6.54%+52.62%+120.05% 23.6B
Weighted average by Cap. +2.17%+6.09%+56.77%+134.98%

Financials

2026 *2027 *
Net sales 4.13M 3.61M 3.31M 3.09M 5.86M 393M 5.95M 39.88M 15.45M 193M 15.5M 15.16M 664M 4.92M 4.3M 3.95M 3.69M 6.99M 469M 7.1M 47.58M 18.44M 230M 18.49M 18.09M 792M
Net income -33.21M -29.02M -26.65M -24.85M -47.12M -3.16B -47.91M -321M -124M -1.55B -125M -122M -5.34B -39.93M -34.89M -32.04M -29.88M -56.64M -3.8B -57.6M -386M -149M -1.86B -150M -147M -6.42B
Net Debt - -
Logo Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. The Company has developed the RaniPill capsule, which is a proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. The RaniPill capsule is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. It has two configurations of the platform: the RaniPill GO and the RaniPill HC. The RaniPill GO is designed to deliver up to a 3 mg dose of drug in microtablet form with high bioavailability. It is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC. Its product candidate pipeline includes obesity programs (RT-114 and RT-116), immunology programs (RT-105 and RT-111) and endocrinology programs (RT-102 and RT-110).
Employees
70
Date Price Change Volume
02/07/26 $0.7707 +0.30% 456,832
01/07/26 $0.7684 +1.05% 473,116
30/06/26 $0.7604 -0.56% 213,003
29/06/26 $0.7647 +3.91% 545,525
26/06/26 $0.7359 -0.86% 830,349
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.7684USD
Average target price
7.500USD
Spread / Average Target
+876.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RANI Stock